VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by snuff69on Jan 14, 2018 10:28pm

279 Views

Post# 27355886

Nr

For all the long time high stake holder they would have received an email nr the other day , but only us would have seen this , I figured I would post it to show that GA does a lot of work behind the scenes that he does not release and he doesn’t really care about the day to day stock price .He has worked here for some months ??, so what else is on the go ??. Another news release is coming this week

Dear Stakeholder;

Attached is a self-explanatory news release.

Dave McPhedran has been representing the company in Canada for some months and now has signed on permanently to drive sales in North America. He has been with Siemens for 10 years in imaging sales so has excellent credentials to lead our sales efforts.

We expect to enlarge the group further when we get FDA approval in the next few months.

Thanks for the continued support.

Regards,

George Adams, PhD, ICD.D
President and CEO
Ventripoint Diagnostics Ltd..
Cell: 519-803-6937
TSXV: VPT
www.ventripoint.com
The world's first •dot imaging• comp